Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

88 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies.
Garjani A, Middleton RM, Hunter R, Tuite-Dalton KA, Coles A, Dobson R, Duddy M, Hughes S, Pearson OR, Rog D, Tallantyre EC, das Nair R, Nicholas R, Evangelou N. Garjani A, et al. Among authors: tallantyre ec. Mult Scler Relat Disord. 2021 Jul;52:102939. doi: 10.1016/j.msard.2021.102939. Epub 2021 May 5. Mult Scler Relat Disord. 2021. PMID: 34010764 Free PMC article.
Spotlight on teriflunomide.
Tallantyre E, Evangelou N, Constantinescu CS. Tallantyre E, et al. Int MS J. 2008 Jun;15(2):62-8. Int MS J. 2008. PMID: 18782502 Review.
3 Tesla and 7 Tesla MRI of multiple sclerosis cortical lesions.
Tallantyre EC, Morgan PS, Dixon JE, Al-Radaideh A, Brookes MJ, Morris PG, Evangelou N. Tallantyre EC, et al. J Magn Reson Imaging. 2010 Oct;32(4):971-7. doi: 10.1002/jmri.22115. J Magn Reson Imaging. 2010. PMID: 20882628
88 results